Decreased CSF Aβ42 correlates with brain atrophy in cognitively normal elderly

od Fagan, Anne M., Head, Denise, Shah, Aarti R., Marcus, Daniel, Mintun, Mark, Morris, John C., Holtzman, David M.
Wydane 2009

Neutrophil elastase and neurovascular injury following focal stroke and reperfusion

od Stowe, Ann M., Adair-Kirk, Tracy L., Gonzales, Ernesto R., Perez, Ronald S., Shah, Aarti R., Park, Tae S., Gidday, Jeffrey M.
Wydane 2009

CSF Proteins Predict Longitudinal Hippocampal Degeneration in Early Stage Dementia of the Alzheimer Type

od Wang, Lei, Fagan, Anne M., Shah, Aarti R., Beg, Mirza Faisal, Csernansky, John G., Morris, John C., Holtzman, David M.
Wydane 2012

Reduction of Leukocyte Microvascular Adherence and Preservation of Blood-Brain Barrier Function by Superoxide-Lowering Therapies in a Piglet Model of Neonatal Asphyxia

od Ruden, Jacob B., Quick, Kevin L., Gonzales, Ernesto R., Shah, Aarti R., Park, T. S., Kennedy, Nan, Dugan, Laura L., Gidday, Jeffrey M.
Wydane w Front Neurol (2019)

Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease

od Fagan, Anne M, Mintun, Mark A, Shah, Aarti R, Aldea, Patricia, Roe, Catherine M, Mach, Robert H, Marcus, Daniel, Morris, John C, Holtzman, David M
Wydane 2009

Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms

od Wahrle, Suzanne E, Shah, Aarti R, Fagan, Anne M, Smemo, Scott, Kauwe, John SK, Grupe, Andrew, Hinrichs, Anthony, Mayo, Kevin, Jiang, Hong, Thal, Leon J, Goate, Alison M, Holtzman, David M
Wydane 2007

Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease

od Perrin, Richard J., Craig-Schapiro, Rebecca, Malone, James P., Shah, Aarti R., Gilmore, Petra, Davis, Alan E., Roe, Catherine M., Peskind, Elaine R., Li, Ge, Galasko, Douglas R., Clark, Christopher M., Quinn, Joseph F., Kaye, Jeffrey A., Morris, John C., Holtzman, David M., Townsend, R. Reid, Fagan, Anne M.
Wydane 2011

Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age

od Sutphen, Courtney L., Jasielec, Mateusz S., Shah, Aarti R., Macy, Elizabeth M., Xiong, Chengjie, Vlassenko, Andrei G., Benzinger, Tammie L. S., Stoops, Erik E. J., Vanderstichele, Hugo M. J., Brix, Britta, Darby, Heather D., Vandijck, Manu L. J., Ladenson, Jack H., Morris, John C., Holtzman, David M., Fagan, Anne M.
Wydane w JAMA Neurol (2015)

SNPs Associated with Cerebrospinal Fluid Phospho-Tau Levels Influence Rate of Decline in Alzheimer's Disease

od Cruchaga, Carlos, Kauwe, John S. K., Mayo, Kevin, Spiegel, Noah, Bertelsen, Sarah, Nowotny, Petra, Shah, Aarti R., Abraham, Richard, Hollingworth, Paul, Harold, Denise, Owen, Michael M., Williams, Julie, Lovestone, Simon, Peskind, Elaine R., Li, Ge, Leverenz, James B., Galasko, Douglas, Morris, John C., Fagan, Anne M., Holtzman, David M., Goate, Alison M.
Wydane 2010

BRAIN ABNORMALITIES IN YOUNG ADULTS AT GENETIC RISK FOR AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE: A CROSS-SECTIONAL STUDY

od Reiman, Eric M., Quiroz, Yakeel T., Fleisher, Adam S., Chen, Kewei, Velez-Pardo, Carlos, Jimenez-Del-Rio, Marlene, Fagan, Anne M., Shah, Aarti R., Alvarez, Sergio, Arbelaez, Andrés, Giraldo, Margarita, Acosta-Baena, Natalia, Sperling, Reisa A., Dickerson, Brad, Stern, Chantal E., Tirado, Victoria, Munoz, Claudia, Reiman, Rebecca A., Huentelman, Matthew J., Alexander, Gene E., Langbaum, Jessica B.S., Kosik, Kenneth S., Tariot, Pierre N., Lopera, Francisco
Wydane 2012